Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Most Ditch GLP-1 Drugs for Weight Loss Within a Year
Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly higher for patients without versus with type 2 diabetes (64.8% vs 46.5%), reported Ezekiel J. Emanuel, MD, PhD, of the University of Pennsylvania in Philadelphia, and colleagues.
Josh Gad opens up for 1st time about taking weight loss drug: 'It is life-changing'
"I’m on a GLP-1," Gad revealed during the conversation with Dax Shepard and Monica Padma, noting that this is his first time speaking out publicly about the topic. "It has suppr
Josh Gad Has Lost 40 Lbs on GLP-1 Medication: 'It Is a Miracle Drug'
Josh Gad is opening up about the weight loss success he's had with GLP-1 medication - and sharing some of the conflicted feelings he's had along the way. "I'm on a GLP-1 … this is the first time I've opened up about this,
Josh Gad Reveals How Much Weight He's Lost on GLP-1 Medication
GLP-1 medications such as Ozempic and Wegovy have had a transformative effect for those struggling with weight loss. Many celebrities have joined the ranks of those who swear by the medication, including Josh Gad,
Josh Gad Makes Bold Declaration About Weight Loss Drugs After Losing 40 Pounds
Josh Gad is the latest celebrity to talk about using a weight loss medication—and while his experience has been positive, he does have some doubts about his transformation. “I’m on a GLP-1...this is the first time I’ve opened up about this,
Josh Gad credits 'miracle drug' with helping him lose 40 pounds
During an interview for the Armchair Expert podcast on Monday, the actor revealed that he has been taking a GLP-1 medication for weight loss. "I'm on a GLP-1... this is the first time I've opened up about this,
3h
on MSN
Scouted: ‘Nature’s Ozempic’? Experts Weigh in on the Budding GLP-1 Supplement Boom
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...
MedPage Today
4h
Ophthalmic Complications Observed After Use of GLP-1 Agonists
The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...
9h
on MSN
How GLP-1 medications are transforming diabetes and weight loss treatment
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
2d
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
BioSpace
8h
Fractyl Goes All In on GLP-1 Off-Ramp Drug, Lays of 17% of Workforce
Fractyl Health is deprioritizing a type 2 diabetes trial in favor of a pivotal study of its endoscopy treatment Revita and ...
Health and Me on MSN
1d
GLP-1 Drugs Affect 175 Health Conditions, Benefits Heart But Pose Risk To Kidneys
A new study has examined the effects of GLP-1 drugs on 175 different health outcomes. ​​​While these drugs have been found to ...
5d
GLP-1 Users Are Spending Way Less on Groceries and Fast Food, According to a New Study
Snack foods and sweet treats have seen a decline in purchases, as people reach for more nutrient-dense options.
6d
GLP-1 drugs like Ozempic may have health benefits, but they come with risks
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
Medscape
2d
GLP-1 for Complex Cases: Breakthrough Therapies That Transform Patient Care
Unlock the potential of GLP-1 therapies! Join experts to explore cutting-edge strategies for managing cardiovascular & ...
MassDevice
6h
ResMed revenue up 10% in Q2 — but GLP-1 questions remain
ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...
6h
Roche Q4 Earnings Review: Solid All-Court Performance, But Quiet On GLP-1 Progress
Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...
1h
on MSN
New study reveals why patients stop taking GLP-1 obesity drugs
Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why GLP-1 users stop taking the drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Thyroid Cancer
Glucagon-like peptide-1
Josh Gad
Food and Drug Administration
Feedback